Anti-Ro60 autoantibodies demonstrated a high prevalence in the non-ILD SjD (63%) and SjD-ILD (80%) patients but were only present in 5 (16%) patients in the IIM cohort (Figure 3B). The gene discussed is RO60; the disease is interstitial lung disease.